« Back
Home /
Semaxinib

Semaxinib

Manufacturer	MedChem Express
Category	Oncology Metabolism Diabetes Cholesterol & Lipid Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Colorectal Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10mM/1mL
Item no.	HY-10374-10mM
Targets	VEGFR
CASRN	204005-46-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Semaxinib (SU5416) is a potent and selective inhibitor of VEGFR (Flk-1/KDR) with an IC50 of 1.23 μM[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	238.28
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer
Solubility	DMF : 50 mg/mL (ultrasonic)\|DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	VEGFR
Isoform	VEGFR2/KDR/Flk-1
Pathway	Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-10374-10mM-safety-datasheet.pdf